Orchestra BioMed Holdings (OBIO) Current Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Current Assets for 7 consecutive years, with $96.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 85.36% year-over-year to $96.2 million; the TTM figure through Mar 2026 stood at $96.2 million (up 85.36% YoY), while the FY2025 annual figure was $107.9 million, up 56.01% from the prior year.
• Current Assets fell to $96.2 million in Q1 2026 per OBIO's latest filing, from $107.9 million in the prior quarter.
• Across five years, Current Assets topped out at $129.9 million in Q1 2023 and bottomed at $872555.0 in Q3 2022.
• Historically, Current Assets has averaged $71.0 million across 5 years, with a median of $76.4 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets sank 53.2% — and 2023, when it jumped 12528.32%.
• Orchestra BioMed Holdings' Current Assets stood at $84.7 million in 2022, then climbed by 5.22% to $89.1 million in 2023, then retreated by 22.38% to $69.2 million in 2024, then jumped by 56.01% to $107.9 million in 2025, then retreated by 10.84% to $96.2 million in 2026.
• Business Quant data shows OBIO's Current Assets at $96.2 million in Q1 2026, $107.9 million in Q4 2025, and $97.8 million in Q3 2025.